loading
Precedente Chiudi:
$1.40
Aprire:
$1.41
Volume 24 ore:
6,614
Relative Volume:
0.43
Capitalizzazione di mercato:
$16.16M
Reddito:
$996.00K
Utile/perdita netta:
$-6.09M
Rapporto P/E:
0.314
EPS:
4.49
Flusso di cassa netto:
$-9.76M
1 W Prestazione:
+5.22%
1M Prestazione:
-11.32%
6M Prestazione:
-34.11%
1 anno Prestazione:
-49.46%
Intervallo 1D:
Value
$1.40
$1.4165
Intervallo di 1 settimana:
Value
$1.32
$1.44
Portata 52W:
Value
$1.15
$2.9899

Therapeuticsmd Inc Stock (TXMD) Company Profile

Name
Nome
Therapeuticsmd Inc
Name
Telefono
561-961-1900
Name
Indirizzo
951 YAMATO ROAD, SUITE 220, BOCA RATON, FL
Name
Dipendente
1
Name
Cinguettio
@TherapeuticsMD
Name
Prossima data di guadagno
2024-11-12
Name
Ultimi documenti SEC
Name
TXMD's Discussions on Twitter

Confronta TXMD con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Drug Manufacturers - Specialty & Generic icon
TXMD
Therapeuticsmd Inc
1.41 16.16M 996.00K -6.09M -9.76M 4.49
Drug Manufacturers - Specialty & Generic icon
ZTS
Zoetis Inc
176.74 80.59B 9.15B 2.43B 2.31B 4.92
Drug Manufacturers - Specialty & Generic icon
HLN
Haleon Plc Adr
9.72 44.17B 14.26B 1.55B 0 0.3327
Drug Manufacturers - Specialty & Generic icon
TAK
Takeda Pharmaceutical Co Adr
13.57 42.61B 30.27B 1.93B 3.45B 0.444
Drug Manufacturers - Specialty & Generic icon
TEVA
Teva Pharmaceutical Industries Ltd Adr
16.57 18.77B 16.77B -959.00M 1.37B -2.00
Drug Manufacturers - Specialty & Generic icon
VTRS
Viatris Inc
13.22 15.73B 15.05B -883.30M 1.89B 1.53

Therapeuticsmd Inc Stock (TXMD) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2020-08-07 Downgrade Jefferies Hold → Underperform
2020-05-19 Downgrade JP Morgan Overweight → Neutral
2019-12-02 Iniziato Guggenheim Buy
2019-10-17 Iniziato H.C. Wainwright Buy
2019-04-30 Ripresa Noble Capital Markets Outperform
2018-06-15 Iniziato JP Morgan Overweight
2017-09-08 Iniziato Morgan Stanley Equal-Weight
2017-07-11 Aggiornamento Oppenheimer Perform → Outperform
2017-05-09 Downgrade Oppenheimer Outperform → Perform
2016-11-22 Ripresa Jefferies Buy
2016-11-22 Iniziato Oppenheimer Outperform
2016-11-07 Ripresa Guggenheim Buy
2016-04-04 Iniziato Goldman Buy
2015-12-08 Reiterato Jefferies Buy
2015-12-08 Reiterato Stifel Buy
2015-09-21 Reiterato Jefferies Buy
2015-06-09 Iniziato Guggenheim Buy
2014-07-08 Iniziato FBR Capital Outperform
2014-04-17 Reiterato Noble Financial Buy
2014-01-28 Reiterato Noble Financial Buy
Mostra tutto

Therapeuticsmd Inc Borsa (TXMD) Ultime notizie

pulisher
Nov 26, 2024

TherapeuticsMD Inc. stock underperforms Tuesday when compared to competitors despite daily gains - MarketWatch

Nov 26, 2024
pulisher
Nov 25, 2024

TherapeuticsMD Inc. stock outperforms competitors on strong trading day - MarketWatch

Nov 25, 2024
pulisher
Nov 22, 2024

TherapeuticsMD Inc. stock underperforms Friday when compared to competitors despite daily gains - MarketWatch

Nov 22, 2024
pulisher
Nov 21, 2024

TherapeuticsMD Inc. stock underperforms Thursday when compared to competitors - MarketWatch

Nov 21, 2024
pulisher
Nov 20, 2024

TXMD (TherapeuticsMD) Days Inventory : 0.00 (As of Sep. 2024) - GuruFocus.com

Nov 20, 2024
pulisher
Nov 19, 2024

TherapeuticsMD Inc. stock rises Tuesday, still underperforms market - MarketWatch

Nov 19, 2024
pulisher
Nov 18, 2024

TherapeuticsMD Inc. stock underperforms Monday when compared to competitors - MarketWatch

Nov 18, 2024
pulisher
Nov 15, 2024

TherapeuticsMD Inc. stock underperforms Friday when compared to competitors - MarketWatch

Nov 15, 2024
pulisher
Nov 15, 2024

TXMD stock touches 52-week low at $1.43 amid market challenges - Investing.com

Nov 15, 2024
pulisher
Nov 15, 2024

TherapeuticsMD Third Quarter 2024 Earnings: US$0.049 loss per share (vs US$0.13 loss in 3Q 2023) - Yahoo Finance

Nov 15, 2024
pulisher
Nov 15, 2024

TherapeuticsMD, Inc. (NASDAQ:TXMD) Sees Large Increase in Short Interest - Defense World

Nov 15, 2024
pulisher
Nov 13, 2024

TherapeuticsMD Inc. stock outperforms competitors despite losses on the day - MarketWatch

Nov 13, 2024
pulisher
Nov 12, 2024

TherapeuticsMD Reports Reduced Losses Amid Strategic Shift - TipRanks

Nov 12, 2024
pulisher
Nov 12, 2024

TherapeuticsMD: Q3 Earnings Snapshot - Houston Chronicle

Nov 12, 2024
pulisher
Nov 12, 2024

TherapeuticsMD Inc (TXMD) Reports Third Quarter 2024 Earnings: S - GuruFocus.com

Nov 12, 2024
pulisher
Nov 12, 2024

TherapeuticsMD Announces Third Quarter 2024 Financial Results - BioSpace

Nov 12, 2024
pulisher
Nov 12, 2024

TherapeuticsMD Shifts Focus with Lower Q3 Losses - TipRanks

Nov 12, 2024
pulisher
Nov 12, 2024

TherapeuticsMD Narrows Q3 Loss by 60%, Weighs Strategic Options Amid Revenue Growth | TXMD Stock News - StockTitan

Nov 12, 2024
pulisher
Nov 11, 2024

TherapeuticsMD Inc. stock remains steady Monday, underperforms market - MarketWatch

Nov 11, 2024
pulisher
Nov 08, 2024

TherapeuticsMD Inc. stock remains steady Friday, underperforms market - MarketWatch

Nov 08, 2024
pulisher
Nov 06, 2024

TherapeuticsMD Inc. stock remains steady Wednesday, underperforms market - MarketWatch

Nov 06, 2024
pulisher
Nov 05, 2024

TherapeuticsMD Inc. stock underperforms Tuesday when compared to competitors - MarketWatch

Nov 05, 2024
pulisher
Oct 31, 2024

TherapeuticsMD Inc. stock remains steady Thursday, still outperforms market - MarketWatch

Oct 31, 2024
pulisher
Oct 30, 2024

TherapeuticsMD Inc. stock underperforms Wednesday when compared to competitors - MarketWatch

Oct 30, 2024
pulisher
Oct 24, 2024

TherapeuticsMD Inc. stock rises Thursday, still underperforms market - MarketWatch

Oct 24, 2024
pulisher
Oct 17, 2024

TherapeuticsMD Inc. stock remains steady Thursday, underperforms market - MarketWatch

Oct 17, 2024

Therapeuticsmd Inc Azioni (TXMD) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading

Therapeuticsmd Inc Azioni (TXMD) insider trading

Commercio interno Relazione Data Transazione Costo #Azioni Valore ($) #Azioni Totale
Collins Cooper C.
Director
Aug 21 '24
Buy
1.70
1,200
2,039
47,922
Walker Marlan D
Chief Executive Officer
Dec 05 '23
Option Exercise
0.00
70,000
0
81,615
Walker Marlan D
Chief Executive Officer
Dec 06 '23
Sale
2.31
14,500
33,496
67,115
Walker Marlan D
Chief Executive Officer
Dec 07 '23
Sale
2.24
4,550
10,187
62,565
$90.27
price up icon 0.83%
$13.13
price up icon 0.00%
$86.59
price up icon 0.19%
$61.00
price up icon 0.41%
$126.59
price down icon 1.03%
$13.22
price up icon 1.07%
Capitalizzazione:     |  Volume (24 ore):